We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$17.3B
AUM Growth
-$1.13B
Cap. Flow
-$75.7M
Cap. Flow %
-0.44%
Top 10 Hldgs %
25.36%
Holding
830
New
93
Increased
230
Reduced
369
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.67%
3 Financials 12.95%
4 Communication Services 7.42%
5 Consumer Discretionary 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSTM icon
601
HealthStream
HSTM
$828M
$391K ﹤0.01%
18,400
-14,900
-45% -$339K
LAD icon
602
Lithia Motors
LAD
$8.31B
$386K ﹤0.01%
1,800
-100
-5% -$26.1K
HBNC icon
603
Horizon Bancorp
HBNC
$1.06B
$384K ﹤0.01%
21,365
-21,735
-50% -$409K
FISI icon
604
Financial Institutions
FISI
$838M
$381K ﹤0.01%
15,813
-11,513
-42% -$299K
FL
605
DELISTED
Foot Locker
FL
$377K ﹤0.01%
12,100
+2,400
+25% +$76.6K
MD icon
606
Pediatrix Medical
MD
$2.16B
$376K ﹤0.01%
+22,800
New +$459K
MHO icon
607
M/I Homes
MHO
$3.8B
$374K ﹤0.01%
10,335
-3,100
-23% -$134K
RJF icon
608
Raymond James Financial
RJF
$34.1B
$366K ﹤0.01%
+3,700
New +$375K
VVV icon
609
Valvoline
VVV
$4.95B
$365K ﹤0.01%
+14,400
New +$421K
HIG icon
610
Hartford Financial Services
HIG
$39.2B
$359K ﹤0.01%
5,800
+1,100
+23% +$71.6K
JOUT icon
611
Johnson Outdoors
JOUT
$502M
$359K ﹤0.01%
6,999
-6,247
-47% -$391K
EXEL icon
612
Exelixis
EXEL
$13.8B
$343K ﹤0.01%
21,900
+3,800
+21% +$73.4K
WLY icon
613
John Wiley & Sons Class A
WLY
$2.7B
$342K ﹤0.01%
+9,100
New +$432K
LOW icon
614
Lowe's Companies
LOW
$119B
$338K ﹤0.01%
1,800
-68,802
-97% -$13.4M
EPM icon
615
Evolution Petroleum
EPM
$129M
$333K ﹤0.01%
47,849
-28,211
-37% -$186K
OXM icon
616
Oxford Industries
OXM
$568M
$332K ﹤0.01%
+3,700
New +$358K
SENEA icon
617
Seneca Foods Class A
SENEA
$1.15B
$330K ﹤0.01%
6,544
-5,400
-45% -$297K
VIVO
618
DELISTED
Meridian Bioscience Inc
VIVO
$325K ﹤0.01%
10,300
-11,300
-52% -$366K
SHEL icon
619
Shell
SHEL
$252B
$323K ﹤0.01%
6,500
-203,800
-97% -$10.5M
PINC
620
DELISTED
Premier
PINC
$322K ﹤0.01%
9,500
+1,800
+23% +$65.6K
TRV icon
621
Travelers Companies
TRV
$78B
$318K ﹤0.01%
2,073
-3,000
-59% -$488K
EMR icon
622
Emerson Electric
EMR
$86.7B
$315K ﹤0.01%
4,300
-74,094
-95% -$6.15M
MSM icon
623
MSC Industrial Direct
MSM
$6.98B
$313K ﹤0.01%
4,300
-5,800
-57% -$457K
PAHC icon
624
Phibro Animal Health
PAHC
$1.51B
$309K ﹤0.01%
23,250
-14,550
-38% -$251K
ILMN icon
625
Illumina
ILMN
$30B
$305K ﹤0.01%
1,645
+206
+14% +$40.8K

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2022 Portfolio in Review

As of Q3 2022, Grantham, Mayo, Van Otterloo & Co (GMO) held 830 positions worth $17.3B, down 6.1% from $18.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2022 filing shows 93 new, 230 increased, 369 reduced and 118 closed positions. Its largest new stake was VMware, Inc: 475,895 shares worth $50.7M. The largest sale was Apple, an estimated $127M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2022 buy was VMware, Inc: 475,895 shares worth $50.7M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Johnson & Johnson in Q3 2022, an estimated $123M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2022 reduction was Apple, cutting an estimated $127M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Healthcare Realty in Q3 2022, selling an estimated $55.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 25% of its $17.3B portfolio in Q3 2022.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 93 new positions and closed 118 in Q3 2022.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 6.1% quarter-over-quarter to $17.3B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.